Breaking News, Collaborations & Alliances

Diamond Pharma Services Supports GenSight Biologics

Provides EU regulatory, pharmacovigilance, quality and compliance support for LUMEVOQ.

By: Contract Pharma

Contract Pharma Staff

Diamond Pharma Services, a technical services and regulatory affairs consulting group, provided EU regulatory, pharmacovigilance, quality and compliance support to GenSight Biologics, including the preparation, authoring support, agency communication and submission of GenSight’s first Marketing Authorization Application to the European Medicines Agency (EMA), for its novel ocular gene therapy LUMEVOQ. The EMA decision is expected in the second half of 2021.   LUMEVOQ (Lenadogene nolparvovec) is ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters